drugset / Trial / NCT06093945

Effect of Omeprazole on Pharmacokinetics of SHR2554 in Healthy Subjects

NCT06093945

Phase 1 Completed 20 enrolled Jiangsu HengRui Medicine Co., Ltd.
NaSingle-groupOpen-labelTreatment

Summary

The study aimed to assess the effects of omeprazole on single-dose SHR2554 in healthy subjects, exploring the pharmacokinetic changes of SHR2554 and ensuring the safety when SHR2554 is co-administered with omeprazole.

Timeline

Start
2023-11-06
Primary completion
2023-11-29
Completion
2023-11-29

Drugs

EvaluationDrugModalityDoseRoute
Subject Omeprazole Other / unclassified
Subject SHR2554 Small molecule 350 mg

Indications